Overview

Ketamine for Acute Suicidal Ideation in the Emergency Department: Randomized Controlled Trial

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
This study will enroll patients presenting to the emergency department with acute suicidal ideation meeting inclusion and exclusion criteria. Patients will be randomized to one of three arms: ketamine (intervention) or diphenhydramine (control) or placebo (control). Serial measurements will be made in the ED and at follow-up intervals.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Brooke Army Medical Center
Treatments:
Ketamine
Criteria
Inclusion Criteria:

- Patients age 18 to less than 75 who present to the SAMMC ED with either overt or
incidental suicidal ideations with a SADPERSONS score 5 or greater that the treating
provider feels warrant formal evaluation.

Exclusion Criteria:

- -Poor vital sign stability hypoxia: O2 < 95%, hypotension: SBP< 90 hypertension:
SBP>180 Heart rate: < 50 or >120 Respiratory Rate: <10 or >30

- Altered mental status or intoxication

- Patient is unwilling to participate or provide informed consent

- Any allergy to ketamine or diphenhydramine

- Patient is female of child-bearing age and unwilling to provide urine or blood for HCG
analysis

- Pregnancy or breast feeding

- Presence of chronic oxygen-dependent pulmonary disease, liver cirrhosis, or renal
disease requiring dialysis

- Presence of ischemic heart disease, heart failure, or a history of unstable
dysrhythmias

- Presence of intracranial mass or vascular lesion.

- Presence of a history of psychosis or hallucinations (as assessed by electronic chart
review)

- Weight greater than 115 kg or less than 45kg

- History of increased intracranial pressure/hypertensive hydrocephalus

- Non-English speaking patients

- Patient is acutely psychotic

- Provider feels that patient currently or likely will require chemical and/or physical
restraints

- History of prolonged QT-interval